- Home
- SIGI vs AAPG Comparison
SIGI vs AAPG Comparison
Compare SIGI & AAPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIGI
- AAPG
- Stock Information
- Founded
- SIGI 1926
- AAPG 2009
- Country
- SIGI United States
- AAPG China
- Employees
- SIGI N/A
- AAPG N/A
- Industry
- SIGI Property-Casualty Insurers
- AAPG Biotechnology: Pharmaceutical Preparations
- Sector
- SIGI Finance
- AAPG Health Care
- Exchange
- SIGI Nasdaq
- AAPG Nasdaq
- Market Cap
- SIGI 4.7B
- AAPG 4.0B
- IPO Year
- SIGI N/A
- AAPG 2025
- Fundamental
- Price
- SIGI $79.22
- AAPG $41.31
- Analyst Decision
- SIGI Hold
- AAPG Buy
- Analyst Count
- SIGI 7
- AAPG 1
- Target Price
- SIGI $87.33
- AAPG N/A
- AVG Volume (30 Days)
- SIGI 520.0K
- AAPG 9.2K
- Earning Date
- SIGI 10-20-2025
- AAPG 08-20-2025
- Dividend Yield
- SIGI 1.93%
- AAPG N/A
- EPS Growth
- SIGI 66.75
- AAPG N/A
- EPS
- SIGI 6.11
- AAPG N/A
- Revenue
- SIGI $5,112,631,000.00
- AAPG $54,524,554.00
- Revenue This Year
- SIGI $5.66
- AAPG N/A
- Revenue Next Year
- SIGI $6.95
- AAPG $387.72
- P/E Ratio
- SIGI $12.89
- AAPG N/A
- Revenue Growth
- SIGI 12.30
- AAPG N/A
- 52 Week Low
- SIGI $71.75
- AAPG $16.50
- 52 Week High
- SIGI $103.56
- AAPG $48.45
- Technical
- Relative Strength Index (RSI)
- SIGI 49.88
- AAPG N/A
- Support Level
- SIGI $77.63
- AAPG N/A
- Resistance Level
- SIGI $79.43
- AAPG N/A
- Average True Range (ATR)
- SIGI 1.40
- AAPG 0.00
- MACD
- SIGI 0.43
- AAPG 0.00
- Stochastic Oscillator
- SIGI 93.32
- AAPG 0.00
About SIGI Selective Insurance Group Inc.
Selective Insurance Group Inc is a regional property-casualty insurer based in New Jersey, with its operations focused in the New York metropolitan area. The Company has four operating segments: Standard Commercial Lines, Standard Personal Lines, E&S Lines, Investments. Majority of revenue is gained from Standard Personal Lines. Currently company has it's revenues from States of USA and Columbia.
About AAPG Ascentage Pharma Group International American Depository Shares
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.